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Abstract  
AIM: To investigate the association between the circulating vaspin concentration and both of 
glucose homeostasis and insulin resistance in metabolic syndrome (MetS) patients, and also to 
evaluate the metabolic impact of two different dietary therapies on such conditions. 
MATERIALS AND METHODS:  Fifty eight obese female volunteers suffering from MetS, followed a 
specially designed dietary therapy consists of a low caloric balanced diet, accompanied by either 
30% doum biscuits (group A), or whole wheat biscuits (group B) for four weeks (phase 1). During 
the next four weeks, they were continued on the hypocaloric diet alone (phase 2).  
RESULTS: The health effects of two dietary therapies were more prominent in improving the 
biochemical markers of the MetS than in the body weight reduction. The lower levels of serum 
vaspin were significantly increased at the end of the 1
st
 phase in both groups especially group (A). 
Sustained negative correlations were detected between vaspin level and both of C-peptide and 
insulin resistance expressed as modified homeostatic model assessment (M.HOMA). 
CONCLUSION: The effect of the dietary supplements may play a role in alleviating the impact of 
the components of the MetS and may also sustain the level of the vaspin in the sensitization of the 
C-peptide in order to attain glucose homeostasis.  
 
 
 
 
 
Introduction 
Vaspin (visceral adipose tissue-derived 
serpin; serpinA12) was originally identified as an 
adipokine, which is predominantly secreted from 
visceral adipose tissue in Otsuka Long-Evans 
Tokushima fatty (OLETF), an animal model of obesity 
and type 2 diabetes. Rat, mouse and human vaspins 
are made up of 392, 394, and 395 amino acids 
respectively; exhibit approximately 40% homology 
with alpha 1- antitrypsin: and are related to serine 
protease inhibitor family (vaspin 1). Consistent with 
that higher vaspin serum concentrations and 
increased vaspin mRNA expression in human adipose 
tissue were found to be associated with obesity, 
insulin resistance, and type 2 diabetes in humans. 
However, the mechanisms how vaspin secretion may 
be linked to deterioration of glucose metabolism and 
insulin sensitivity are not entirely understood [1]. 
The induction of vaspin mRNA expression 
could represent a compensatory mechanism 
associated with obesity, severe insulin resistance and 
type 2 diabetes mellitus; however it is unclear whether 
a correlation exists between human vaspin serum 
levels and markers of insulin sensitivity and glucose or 
lipid metabolism [2]. Vaspin serum concentrations 
show a food intake-related diurnal variation. Vaspin is 
also expressed in the skin, hypothalamus, pancreatic 
islets, and stomach. Administration of vaspin to obese 
mice improves glucose tolerance, insulin sensitivity, 
and reduces food intake [1].  
Until now molecular target(s) of vaspin and its 
mode of action are unknown. Thus, identification of 
the proteases, which are inhibited by vaspin may lead 
to the development of novel strategies in the 
treatment of obesity, diabetes and insulin resistance 
[1].  Vaspin serum concentrations have been shown to 
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be lower in lean subjects and competitive sportsmen 
with long-term physical training, but they are 
increased with weight loss associated with a physical 
training programme. In conclusion, there is at present 
no clear proof of a causal link between vaspin and 
visceral fat accumulation, or insulin resistance [2]. 
Long-term high-fat diet could induce obesity 
metabolic syndrome in Sprague Dawley (SD) rats and 
finally lead to lower vaspin of sera and periepididymal 
fat, while pioglitazone and chronic calorie-control 
ingestion could enhance the production of vaspin. It 
was undoubtedly demonstrated that vaspin 
expression was strongly associated with insulin 
sensitivity, serum free fatty acids (FFA), and tumor 
necrosis factor-alpha (TNF α) [3]. 
Previous studies on doum (Hyphaene 
Thebaica) had focused on the fruit because of its 
nutritional value and its anti- inflammatory effect. It 
was reported that diet supplementation with some 
Egyptian plants like fennel, carob and doum have a 
promising anti - inflammatory influence on attenuating 
the complications associated with the renal 
dysfunction [4]. Research on the fruit pulp showed 
that it contains nutritional trace minerals, proteins, and 
fatty acids, in particular the nutritional essential linoleic 
acid [5]. Doum was reported to contain important 
substances including saponins, tannins, and 
flavonoids [6]. Grains high in insoluble fiber (wheat) 
moderately lower the blood glucose, blood pressure 
levels, visceral obesity and also have a prebiotic effect 
[7]. 
The aim of this study was to investigate the 
association between the circulating vaspin 
concentration in MetS syndrome patients and both 
glucose homeostasis and insulin sensitivity, in 
addition to investigating the metabolic impact of two 
different dietary therapies in such conditions. 
 
Materials and Methods 
Materials 
Wheat grains (Giza 168) was purchased from 
Wheat Research Department, dleiF Research 
Institute, Agric. Res. Center, Giza, Egypt. Wheat flour 
(WF) 72% extraction was purchased from the North 
Cairo Flour Mills Company, Egypt. Dry doum flour was 
obtained from local herbal shop, Dokki, Egypt. 
Skimmed milk, sucrose, shortening, corn oil, baking 
powder, emulsifier, vanilla, bread improver and eggs 
were purchased from the local market, Dokki, Egypt. 
 
Preparation of flour 
Wheat grains (Giza 168) were cleaned, 
tempered (15% moisture) and milled (Quadrumat 
Junior flour mill) to 100 % extraction flour. Whole meal 
wheat flour100 % extraction (WMWF) was well 
blended with doum flour (DF) to produce individual 
mixtures containing 0, 20, 25 and 30% replacement 
levels. All samples were stored in airtight containers 
and kept at 5-7ºC until required. 
 
Preparation and evaluation of biscuits 
Biscuits (basic and modified formulas) were 
prepared by mixing whole meal wheat flour100 % 
extraction with doum flour at levels (0, 20, 25 and 
30%) with other ingredients. Then 14.7 ml of dextrose 
solution (5.93%) and the suitable amount of water 
were added according to AOAC (2000) [8]. These 
formulas were baked in a special oven at 200 °C for 
about 15 minutes, Table 1. According to the panel test 
that was carried out, 30% doum biscuit was the 
choice, formula (5), to be compared with 100% whole 
meal wheat flour, formula (2). 
Table 1: Composition of mixtures used in manufacture of 
biscuits. 
Ingredients (in grams) 
Basic 
formula1 
Modified Biscuits 
 2 3 4 5 
Wheat flour  (WF 72% extraction) 100 -- -- -- -- 
Whole meal wheat flour (WMWF) -- 100 80 75 70 
Doum flour (DF) --  20 25 30 
Sucrose 50 -- -- -- -- 
Corn oil 28 5 5 5 5 
Baking powder 1.1 1.1 1.1 1.1 1.1 
Salt 1.0 1.0 1.0 1.0 1.0 
Emulsifier -- 1.0 1.0 1.0 1.0 
Skim milk -- 5 5 5 5 
Eggs 20 -- -- -- -- 
 
 
Analytical methods of the biscuits 
Moisture, crude fiber, ash, protein and fat of 
biscuits were determined according to standard 
method [8]. Total carbohydrates were calculated by 
difference.  Individual elements (Ca, P, K, Na, Fe, and 
Mg) in the two samples of biscuits were determined 
according to the method described by Chapman and 
Pratt (1978) [9]. Polyphenols were determined using 
standard method [10]. 
 
Subjects  
 Fifty eight obese women suffering from 
metabolic syndrome (MetS), shared as volunteers in 
this study which lasted for 8 weeks. They were 
enrolled in program for losing weight in the National 
Research Center (NRC) after taking approval from the 
Ethical Committee of the NRC and written informed 
consent from each of them. The study was divided 
into two phases, phase (1) and phase (2) each one 
lasted for 4 weeks. Their mean age was 48.8±0.87 
years and had a mean BMI of 38.6± 0.90 kg/m². The 
patients were divided into two groups, group (A) and 
group (B). At phase (1), group (A) followed a low 
caloric balanced diet (1000-1200 K calories), 
accompanied by the 30% doum biscuits, that was 
consumed before breakfast (2 biscuits) and before 
dinner (1 biscuit), each biscuit weighed 20g, while 
group (B) consumed the whole wheat (0% DF) 
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biscuits with the same instructions. Phase (2) lasted 
for 4 weeks in which the volunteers were following 
only the same low caloric balanced diet. All women 
were subjected to thorough clinical examination. 
Blood pressure was recorded.  
 
Anthropometric parameters and blood 
pressure measurements  
 Relevant anthropometric measurements were 
reported including height, weight and minimal waist 
circumference (MWC) using standard method [11]. 
Body Mass Index (BMI) was calculated (weight in kg/ 
height² in meter). Blood pressure for each patient was 
measured 3 times and the mean was recorded.  
 
Blood sampling and Biochemical analysis 
Fasting blood samples (after 12 hour fasting) 
were drawn from the patients. Fasting blood glucose 
was determined on fresh samples; other biochemical 
parameters were performed on fasting sera that were 
stored at -70 C° until used. Fasting blood glucose 
(FBG) was determined in fresh samples using glucose 
oxidase   method [12]. Serum total cholesterol, HDL-C 
and triglycerides were done using; cholesterol 
proceed No 1010 [13], Stanbio, HDL-C proceed No 
0599 StanioLiquicolor [14], and triglycerides proceed 
No 2100 [15], (Enzymatic method) respectively. LDL-
C was calculated according to Friedewald equation 
[16]; where LDL-C= (Total Cholesterol) - (HDL-C) - 
(TG/5). 
Serum C peptide was done by ELISA kit. PR. 
Code=2725-300A. Lot#EIA-27K2G1. Monobind, Inc. 
Lake Forest, CA (92630) USA [17]. Modified 
homeostatic model assessment of insulin resistance 
(M.HOMA-IR) =1.5+fasting blood glucose x fasting c- 
peptide/2800 [18]. Quantitative measurement of 
serum vaspin (visceral adipose tissue-derived serpin) 
using the RD191097200R Human Vaspin ELISA 
BioVendor Research and Diagnostic Products, 
Finland [19]. 
All the above mentioned parameters were 
done before the start of the regimen (basal), after 4 
weeks and lastly at the end of the study.  
 
Dietary recalls 
Collecting detailed data about nutritional 
habits and food intake through 24 hour recall. Analysis 
of food items using World Food Dietary Assessment 
System, (WFDAS), 1995, USA, University of 
California. 
Statistical analysis 
All values were expressed as mean value ± 
SE. Two tailed student t-test was used to compare 
between the two groups. Correlation between the 
different parameters was tested by Pearson test. P 
values <0.05 were considered statistically significant. 
SPSS window software version 17.0 (SPSS Inc. 
Chicago, IL, USA, 2008) was used. 
 
Results 
Data presented in Table 2 show the proximate 
composition of the prepared biscuits.  Moisture, crude 
fiber, and ash increased in prepared biscuits with 
increasing the DF level, whereas protein, fat and total 
carbohydrates contents decreased in biscuits 
substituted with DF compared to the biscuit prepared 
from WMWF without DF. Results indicated that 
addition of DF to WMWF caused changes in mineral 
contents (P, K, Ca, Mn, Na and Fe) of biscuits 
samples supplemented with DF. Determination of the 
polyphenol content of both type of biscuits showed 
that the 0% DF biscuit contain 110 mg/100 g while 
30% DF biscuit contain 164.3 mg/100 g. 
Table 2: Compositions of the two types of the biscuits (/100g). 
 
Constituents WMWF Biscuits (0% DF) 30% DF Biscuits 
Moisture (%) 3.82 ± 0.22 4.80 ± 0.12 
Protein (g) 13.5 ± 0.18 11.75 ± 0.34 
Fat (g) 7.25 ± 0.35 6.50 ± 0.15 
Carbohydrates (g)  75.62 ± 0.77 72.45 ± 0.69 
Crude fiber (g) 1.85 ± 0.02 5.60 ± 0.40 
Total Ash (g) 1.78 ± 0.12 3.70 ± 0.25 
Phosphorus (mg) 187 ± 0.12 305 ± 0.11 
Potassium (mg) 115 ± 0.09 290 ± 0.21 
Calcium (mg) 40 ± 0.03 70 ± 0.01 
Magnesium (mg) 115 ± 0.08 84 ± 0.03 
Sodium (mg) 650 ± 0.11 420 ± 0.13 
Iron (mg) 3.5 ± 0.03 2.8 ± 0.01 
Polyphenols (mg) 110.0 ± 0.12 164.3 
Values are means of three determinations ± SE. 
 
Tables 3 & 4 showed a comparison between 
the different macronutrients and micronutrients and 
the percent caloric distribution of the habitual diet of 
the whole sample before starting the regimen and of 
the two regimens phases.  
Table 3: Mean ± SE of the daily nutrients intake at the different 
phases of the study. 
 
Regimen with 30% 
DF 
Biscuits 
Regimen with 
WMWF 
Biscuits 
Habitual diet Nutrients 
1127.18 ± 7.21 1143.39 ± 4.16 2230.02 ± 9.18 Energy (kcal) 
56.97 ± 3.43 58.02 ± 2.33 89.74 ± 4.59 Protein (g) 
142.33 ± 6.22 144.0 ± 6.28 265.90 ± 12.88 Carbohydrate (g) 
34.421 ± 2.14 34.87 ± 1.64 87.19 ± 4.81 Fat (g) 
537.21 ± 5.22 519.21 ± 3.25 765.37 ± 6.20 Calcium (mg) 
12.82 ± 1.42 13.24 ± 0.12 16.69 ± 0.97 Iron (mg) 
1985.40 ± 3.50 2123.46 ± 3.47 3919.55 ± 2.35 Sodium (mg) 
2947.14 ± 3.43 2842.14 ± 3.18 2871.25 ± 5.56 Potassium (mg) 
The data showed the balanced and healthy 
distribution of the macronutrients in the two regimens 
compared to the habitual diet of the patients. 
Table 5 showed the mean± SE of age, 
anthropometric, blood pressure measurements of 
group A and group B at the start of the study and at 
Basic Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
188                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
the end of the two phases of regimen. All the 
anthropometric measurements and the blood pressure 
values of the two groups decreased significantly at 
p<0.05-0.01 at the end of phase (1).  
Table 4: Percent caloric intake from the three main 
macronutrients of the habitual diet of the patients and the two 
different regimens. 
Nutrients 
Habitual 
diet 
Regimen with 
WMWF 
Biscuits 
Regimen with 
30% DF 
biscuits 
Total Calories  
% Calories from protein 
% Calories from 
carbohydrate 
% Calories from fat 
2230.02 
16.1 
 
47.7 
35.2 
1143.4 
20.3 
 
50.4 
27.4 
1127.2 
20.2 
 
50.4 
27.5 
 
Significant reduction of all the anthropometric 
measurements reported in group (A) at the end of 
phase (2), blood pressure values decreased 
numerically, while patients of group (B) showed only 
numerically reduction in the weight, BMI and SBP, but 
significant decrease in the other parameters. 
Table 6 showed the mean value ± SE of the 
biochemical parameters of the two groups at the three 
visits. At phase (1), the results showed significant 
increase in the mean levels of vaspin and HDL-C at 
p<0.05-0.01 among both groups. However, the 
percent increase was higher among group (A). The 
FBG concentration, other lipid parameters, C-peptide 
and M.HOMA-IR showed significant reduction of the 
concentration in both groups, also this decrease was 
higher among group (A), except triglycerides and 
VLDL-C.   At phase (2), the level of HDL-C decreased 
significantly compared to phase (1) between both 
groups, the percent decrease was more among group 
(B), while the other parameters showed significant 
increase which was higher among group (B) 
compared to group (A) except of FBG, vaspin and C-
peptide. Yet, M.HOMA-IR showed no difference 
between the two groups. 
 
 
Table 5:  Mean ± SE of the anthropometric & blood pressure measurements of the two samples at the base and at the two phases 
of the study.  
 
 
Patient’s 
characteristics 
 
 
Age 
(yr) 
 
Height 
(cm) 
 
Weight 
(kg) 
 
BMI 
(Kg/m
2
) 
 
Waist 
(cm) 
 
Abd. 2 
(cm) 
 
Hip 
(cm) 
 
WHR 
(cm/cm) 
 
Biceps 
ext.(cm) 
 
SBP 
(mmHg) 
 
DBP 
(mmHg) 
Basal 
Group (A) 
Group (B) 
 
Phase 1 
Group (A) 
Group (B) 
 
Phase 2 
Group (A) 
Group (B) 
 
% Decrease 
Group (A) 
Basal vs. Ph1 
Ph 1 vs. Ph 2 
 
Group (B) 
Basal  vs. Ph 1  
Ph 1 vs. Ph 2 
 
50.3±0.81 
46.9±0.87 
 
157.9±1.01 
158.0±1.22 
 
96.8± 3.21 
96.5± 3.69 
 
 
93.8± 3.23**
a 
93.8± 3.47**
c
 
 
 
90.9± 3.73**
b 
93.1± 3.61 
 
 
 
3.1 
3.1 
 
 
2.8 
0.8 
 
38.8±1.24 
38.2±1.33 
 
 
37.6±1.23**
a 
37.1±1.22**
c 
 
 
36.6±1.44**
b
 
36.8±1.27 
 
 
 
3.9 
2.7 
 
 
2.9 
0.8 
 
101.9±2.12 
96.1±2.05 
 
 
97.0±2.09**
a
 
92.1±1.99**
c
 
 
 
92.9±2,55**
b
 
90.7±1.88*
d
 
 
 
 
4.8 
4.2 
 
 
4.2 
1.5 
 
122.1±2.34 
120.1±2,48 
 
 
118.8±2.08**
a
 
116.6± 2.29**
c
 
 
 
116.5±2.49*
b
 
115.5±2.34*
d
 
 
 
 
2.7 
1.9 
 
 
2.9 
0.9 
 
123.6±2.12 
122.1±2.33 
 
 
120.0±1.98**
a 
118.8± 2.27**
c 
 
 
118.2±2.45**
b 
116.9±2.21**
d
 
 
 
 
2.9 
1.5 
 
 
2.7 
1.6 
 
0.83± 0.01 
0.79± 0.01 
 
 
0.81±0.01**
a
 
0.78±0.01**
c 
 
 
0.78±0.01**
b
 
0.78±0.01 
 
 
 
2.4 
3.7 
 
 
1.3 
0 
 
34.5± 0.92 
35.1±1.01 
 
 
32.6±0.82**
a 
33.2±0.97**
c 
 
 
31.9±0.97*
b
 
32.7±1.01*
d 
 
 
 
5.5 
2.2 
 
 
5.4 
1.5 
 
137.7±1.91 
138.2±3.27 
 
 
131.9±2.40*
a
 
125.8±3.04**
c 
 
 
128.4±2.85 
123.6±2.51 
 
 
 
4.2 
2.7 
 
 
9.0 
1.8 
 
91.3±1.42 
89.0±1.75 
 
 
86.4±1.17**
a
 
84.6±1.44**
c 
 
 
83.9±1.04 
82.3±1.64*
d
 
 
 
 
5.4 
2.9 
 
 
4.9 
2.7 
 
a&c: Basal  vs.  Phase 1            b&d: Phase1 vs. Phase 2                         Significant at       *p<0.05                   **p<0.01 
 
Table 7 showed the correlation coefficient 
between the vaspin concentration and the different 
MetS criteria in the two groups. No significant 
correlations were reported between the vaspin 
concentrations and the different criteria in group (A), 
at the basal and at the end of the two periods of 
intervention. Group (B) showed significant negative 
correlation with FBG, C-peptide and M.HOMA, at the 
end of phase (1), while at the end of phase (2) 
significant positive correlation with body weight, BMI, 
MWC, SBP and DBP and significant negative 
correlation HDL-C, C-peptide and M.HOMA. 
 
 
Table 6: Mean ± SE of the biochemical parameters of the two groups at the three different visits. 
 
Bioche-mical 
parame-ters 
Vaspin 
(ng/ml) 
FBG 
(mg/dl) 
Triglyceride 
(mg/dl) 
VLDL-C 
(mg/dl) 
T. cholesterol 
(mg/dl) 
LDL-C 
(mg/dl) 
HDL-C 
(mg/dl) 
Non-HDL-C 
(mg/dl) 
Risk  
factor 
C-peptide 
(ng/ml) 
Modified 
HOMA 
Basal 
Group (A) 
Group (B) 
 
Phase (1) 
Group (A) 
Group (B) 
 
Phase (2) 
Group (A) 
Group (B) 
 
% Change 
Group (A) 
B vs. Ph 1 
Ph1 vs.  Ph 2 
 
Group (B) 
B vs. Ph 1 
Ph1 vs. Ph 2 
 
0.23±0.08 
0.40±0.20 
 
 
0.31±0.10
*a 
0.41±0.01
*c 
 
 
0.28±0.11
*b 
0.42±0.20 
 
 
 
17.4 
-9.4 
 
 
2.5 
2.4 
 
128.9±7.14 
106.3±7.13 
 
 
106.9±6.06**
a
 
89.5±3.10*
c
 
 
 
111.3±5.67 
92.7±2.16 
 
 
 
-17.1 
4.1 
 
 
-15.8 
3.6 
 
188.5±13.68 
136.0±8.64 
 
 
149.0±11.68**
a
 
107.1±6.71**
c
 
 
 
156.2±13.88 
122.6±8.51*
d 
 
 
 
-20.5 
4.2 
 
 
-21.3 
14.5 
 
37.7±2.74 
27.2±1.73 
 
 
30.0±2.34**
a
 
21.4±1.34**
c 
 
 
31.2±2.78 
24.5±1.70*
d 
 
 
 
-20.4 
4 
 
 
21.3 
15.9 
 
224.7±6.0 
209±9.21 
 
 
195.3±7.49**
a 
181.8±6.64**
c 
 
 
211.0±6.32*
b 
204.9±10.03**
d 
 
 
 
-13.1 
8.0 
 
 
13.0 
12.7 
 
139.9±4.87 
137.8±8.94 
 
 
105.7±5.97**
a
 
106.2±6.07**
c
 
 
 
124.3±5.62*
b 
130.9±9.44**
d
 
 
 
 
-24.5 
17.6 
 
 
-22.9 
23.3 
 
47.1±1.06 
43.9±2.01 
 
 
59.6±1.44**
a
 
54.2±2.05**
c
 
 
 
55.5±2.45*
b
 
49.5±1.82*
d
 
 
 
 
26.5 
-6.9 
 
 
23.5 
-8.7 
 
177.6±6.26 
165.0±9.37 
 
 
135.7±7.56**
a
 
127.6±6,70**
c 
 
 
155.5±7.90*
b
 
155.4±9.72**
d 
 
 
 
-23.6 
14.6 
 
 
-22.7 
21.8 
 
4.9±0.17 
4.9±0.27 
 
 
3.3±0.16**
a
 
3.4±0.18**
c 
 
 
4.1±0.25**
b 
4.2±0.23**
d 
 
 
 
-32.7 
24.2 
 
 
30.6 
23.5 
 
2.76±0.22 
2.73±0.22 
 
 
2.21±0.22**
a
 
2.43±0.20**
c
 
 
 
2.27±0.19 
2.47±0.22 
 
 
 
19.9 
2.7 
 
 
-11.0 
1.7 
 
1.64±0.02 
1.61±0.01 
 
 
1.59±0.01 
1.58±0.01 
 
 
1.59±0.01 
1.58±0.01 
 
 
 
-3.1 
0 
 
 
-1.9 
0 
Group (A)   a: Basal vs. Phase (1)      b: Phase (1) vs. Phase (2)    Group (B)    c: Basal vs. Phase (1)      d: Phase (1) vs. Phase (2). Significant *P<0.05              **P<0.01. 
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Table 7: Correlation coefficients between vaspin (ng/ml) and different criteria of MetS. 
 
Parameters 
Group (A) 
(no.=34) 
Group (B) 
(no.= 24) 
Basal Phase (1) Phase (2) Basal Phase (1) Phase (2) 
Age (yr) 
Weight (kg) 
BMI (kg/m
2
) 
MWC (cm) 
SBP (mmHg) 
DBP (mmHg) 
FBG (mg/dl) 
TG (mg/dl) 
HDL-C (mg/dl) 
C-peptide (ng/ml) 
M.HOMA 
0.076 
-0.190 
-0.237 
-0.074 
-0.293 
-0.185 
-0.206 
-0.156 
-.0282 
-0.264 
-0.210 
-0.040 
-0.187 
-0.230 
-0.086 
0.000 
0.162 
-0.225 
-0.102 
0.016 
-0.164 
-0.161 
0.048 
-0.200 
-0.250 
-0.111 
0.020 
0.318 
-0.241 
-0.115 
-0.281 
-0.155 
-0.910 
-0.280 
0.082 
0.089 
0.139 
0.248 
0.232 
-0.180 
-0.108 
-0.042 
-0.348 
-0.286 
-0.284 
0.134 
0.152 
0.166 
-0.100 
0.043 
-0.573** 
0.014 
-0.049 
-0.524** 
-0.504* 
-0.298 
0.566** 
0.680** 
0.715** 
0.583** 
0.667** 
0.184 
0.214 
-0.438** 
-0.445** 
-0.485** 
  Numbers presented in this table are the value of r =correlation coefficient; *Correlation is significant at the 0.05 level (2-tailed);  **Correlation is significant at the 0.01 level (2-tailed). 
 
 
Discussion 
It has been reported that abnormality in the 
circulating level of vaspin is related to BMI, visceral 
obesity and insulin sensitivity in the metabolic 
syndrome patients. The objective of this study was to 
explore the effect of special diet therapy on the 
different MetS criteria and to assess the variation in 
vaspin concentration in this condition. In this context 
the findings of this study showed the beneficial 
healthy effects of the two different dietary therapies 
used. However, it is important to report that this effect 
was more prominent in improving the related 
biochemical markers of the MetS than its effect on 
body weight reduction. Furthermore, in the phase (2), 
stopping the use of these dietary supplements that 
were used in conjunction with the hypocaloric regimen 
in phase (1) of the study was followed by an increase 
of biochemical parameters: FBG and the lipid profile, 
with a decrease in the HDL-C in spite of the continual 
decrease in the body weight, BMI and MWC. This 
finding could be attributed to the active biological 
nutritional contents of the doum fruits and the whole 
wheat which could be of great merit for the use with 
such patients. 
Controversial results were reported 
concerning the association between vaspin 
concentration and the MetS criteria. Studies in 
animals indicated that vaspin is an endogenous 
insulin sensitizer [20], and that it is elevated in 
overweight and obese type 2 diabetes [21]. However, 
in humans the effect of vaspin on insulin sensitivity is 
uncertain and the correlation between vaspin and BMI 
is also unclear [19]. Youn et al. [22] reported that 
elevated vaspin levels are associated with decreased 
BMI together with improvement in insulin sensitivity 
and fitness level. Data of this study indicated that in 
group (A), elevation of the MetS components was 
accompanied by lower levels of serum vaspin 
concentration compared to group (B). In addition 
vaspin concentrations were significantly increased 
after the first 4 weeks of dietary therapy in both 
groups, especially in group (A). It is interesting to 
notice here that the percent increase of the serum 
vaspin concentration in group (A) was nearly similar to 
the percent decrease of the levels of FBG and C-
peptide, but less decrease was found in the calculated 
M.HOMA. In phase (2), the variations in vaspin in both 
groups were insignificant.  
Correlation analysis revealed mostly no 
significant correlations throughout the duration of the 
study. However, the elevated levels of vaspin such as 
in the case of group (B) at the end of phase (1) were 
significantly negatively correlated with FBG, C-peptide 
and M.HOMA values; while at the end of phase (2) 
there was a reversal to positive significant correlations 
with BMI, MWC, SBP and DBP while the negative 
correlations were sustained with C-peptid and the 
MHOMA. In this condition we can conclude that the 
association between the MetS criteria was revealed at 
higher levels of the vaspin. The role of vaspin as an 
anti-inflammatory adipokine was suggested by Auguet 
et al. [23], who reported that vaspin may have a 
compensatory role in the underlying inflammation of 
obesity as evidenced by being negatively correlated 
with the inflammatory markers. Hida et al. [20] 
reported that administration of recombinant human 
vaspin improved insulin sensitivity and glucose 
tolerance and reversed the expression of those genes 
that could promote insulin resistance such as leptin, 
resistin and TNF-α in diet-induced obese mice. This is 
in agreement with our findings regarding the detected 
lower levels of the vaspin in group (A) patients which 
exhibited high levels of all MetS components, which 
are well known to be associated with high levels of the 
inflammatory markers. In addition, the elevation of the 
serum vaspin concentration at the end of phase (1) in 
both groups could be attributed to the anti-
inflammatory properties of the two supplements 
working in synergism with vaspin. 
In conclusion, the effect of the supplements 
may play a role in alleviating the impact of the 
components of the MetS and to sustain the level of 
the vaspin in the sensitization of the C-peptide in 
order to attain glucose homeostasis.  
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